These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16279785)

  • 1. Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure.
    Zhou HB; Comninos JS; Stossi F; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2005 Nov; 48(23):7261-74. PubMed ID: 16279785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.
    Wang P; Min J; Nwachukwu JC; Cavett V; Carlson KE; Guo P; Zhu M; Zheng Y; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    J Med Chem; 2012 Mar; 55(5):2324-41. PubMed ID: 22283328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
    Muthyala RS; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2003 Apr; 46(9):1589-602. PubMed ID: 12699377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors.
    Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.
    Zhu M; Zhang C; Nwachukwu JC; Srinivasan S; Cavett V; Zheng Y; Carlson KE; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
    Org Biomol Chem; 2012 Nov; 10(43):8692-700. PubMed ID: 23033157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
    Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD
    J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.
    Zhang S; Wang Z; Hu Z; Li C; Tang C; Carlson KE; Luo J; Dong C; Katzenellenbogen JA; Huang J; Zhou HB
    ChemMedChem; 2017 Feb; 12(3):235-249. PubMed ID: 27976818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
    Zhou HB; Sheng S; Compton DR; Kim Y; Joachimiak A; Sharma S; Carlson KE; Katzenellenbogen BS; Nettles KW; Greene GL; Katzenellenbogen JA
    J Med Chem; 2007 Jan; 50(2):399-403. PubMed ID: 17228884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New synthesis and evaluation of enantiomers of 7-methyl-2-exo-(3'-iodo-5'-pyridinyl)-7-azabicyclo[2.2.1]heptane as stereoselective ligands for PET imaging of nicotinic acetylcholine receptors.
    Gao Y; Horti AG; Kuwabara H; Ravert HT; Holt DP; Kumar A; Alexander M; Wong DF; Dannals RF
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6168-70. PubMed ID: 18930397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
    Clegg NJ; Paruthiyil S; Leitman DC; Scanlan TS
    J Med Chem; 2005 Sep; 48(19):5989-6003. PubMed ID: 16162002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
    Ghosh U; Ganessunker D; Sattigeri VJ; Carlson KE; Mortensen DJ; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2003 Feb; 11(4):629-57. PubMed ID: 12538029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Microcin SF608 through nucleophilic opening of an oxabicyclo[2.2.1]heptane.
    Diethelm S; Schindler CS; Carreira EM
    Org Lett; 2010 Sep; 12(17):3950-3. PubMed ID: 20704315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor.
    Muthyala RS; Carlson KE; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4485-8. PubMed ID: 14643352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
    Mortensen DS; Rodriguez AL; Carlson KE; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2001 Nov; 44(23):3838-48. PubMed ID: 11689070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.